Global Maternal Blood Test Market, By Type (Combined First Trimester Screening, Second Trimester Maternal Serum Screening), Tested Conditions (Edwards Syndrome, Patau Syndrome, Down syndrome, Neural Tube Defects), End- User (Diagnostic Laboratories, Hospitals), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
The maternal blood test market is expected to witness market growth at a rate of 11.30% in the forecast period of 2021 to 2028. Data Bridge Market Research report on maternal blood test market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of maternal blood test market.
Maternal blood test refers to a type of prenatal screening test and provide an assessment of the likelihood of a pregnancy being impacted by a chromosome disorder or certain behavioral issues. The main purpose of the test is ensuring that the baby does not have any chromosome condition such as Down syndrome. These tests are known to possess the ability for improving more information about pregnancy health.
The continuous improvement in reimbursement scenario for NIPT across the globe acts as one of the major factors driving the growth of maternal blood test market. The high risk of chromosomal abnormalities with increasing maternal age, and rise in incidence of chromosomal abnormalities coupled with growing product usage in new applications accelerate the market growth. The rise in preference for noninvasive techniques over invasive methods, and surge in programs focusing on increasing the awareness of NIPT further influence the market. Additionally, surge in healthcare expenditure, favorable reimbursement procedures, and improved chemistry, and bioinformatics analysis positively affects the maternal blood test market. Furthermore, advancements in the existing tests in terms of advanced functions extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, strict regulatory guidelines and ethical hurdles are expected to obstruct the market growth. Lack of skilled and trained professional is projected to challenge the maternal blood test market in the forecast period of 2021 to 2028.
This maternal blood test market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on maternal blood test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Maternal Blood Test Market Scope and Market Size
The maternal blood test market is segmented on the basis of type, tested condition and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the maternal blood test market is segmented into combined first trimester screening, and second trimester maternal serum screening.
- On the basis of tested conditions, the maternal blood test market is segmented into Edwards’s syndrome, patau syndrome, down syndrome and neural tube defects.
- On the basis of end- user, the maternal blood test market is segmented into diagnostic laboratories, and hospitals.
Maternal Blood Test Market Country Level Analysis
The maternal blood test market is analyzed and market size insights and trends are provided by country, type, tested condition and end user as referenced above.
The countries covered in the maternal blood test market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the maternal blood test market because of the high adoption of advanced technologies within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the developing healthcare infrastructure, and rising awareness programs & conferences in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The maternal blood test market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for maternal blood test market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the maternal blood test market. The data is available for historic period 2010-2019.
Competitive Landscape and Maternal Blood Test Market Share Analysis
The maternal blood test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to maternal blood test market.
The major players covered in the maternal blood test market report are CENTOGENE AG, Sequenom., Natera, Inc., LifeLabs Genetics, Progenity, Inc., Sema4, Invitae Corporation., Illumina, Inc., Thermo Fisher Scientific Inc., GENERAL ELECTRIC COMPANY, PerkinElmer, Agilent Technologies, Inc., BGI., F. Hoffmann-La Roche Ltd, YOURGENE HEALTH, Eurofins Scientific, EKF Diagnostics, and NiftyTest, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Maternal Blood Test Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.